Creating a vaccine to protect against multiple types of coronaviruses
Design and Development of a Pan-betacoronavirus Vaccine
This study is working on a new vaccine that could help protect against different types of coronaviruses, including those that caused past outbreaks, so we can be better prepared for any future pandemics.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10327519 on NIH RePORTER |
What this research studies
This research focuses on developing a vaccine that targets a wide range of coronaviruses, including those responsible for past pandemics like SARS and MERS. A team of experts in various fields will work together to create and test these vaccines, ensuring they can effectively stimulate the immune system to recognize and combat these viruses. The approach includes characterizing the immune response to the vaccine candidates and assessing their ability to protect against different strains of coronaviruses. This work aims to prepare for future outbreaks by having effective vaccines ready to deploy quickly.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals at high risk for coronavirus infections, such as healthcare workers and those with underlying health conditions.
Not a fit: Patients who are not at risk for coronavirus infections or those who have already been vaccinated against current strains may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could provide a crucial tool for preventing future coronavirus pandemics, potentially saving countless lives.
How similar studies have performed: Previous research has shown promise in developing vaccines for coronaviruses, but this approach aims to create a more comprehensive solution that has not yet been fully tested.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Haynes, Barton F. — Duke University
- Study coordinator: Haynes, Barton F.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.